Inventor
WEI BINQING
US42 patents
⚠️ This page may combine multiple inventors who share the name “WEI BINQING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
35 patentsUS8716274B2May 6, 2014
Heteroaryl pyridone and aza-pyridone compounds
GENENTECH INC38 citations97
US10045983B2Aug 14, 2018
Heteroaryl pyridone and aza-pyrodine compounds
GENENTECH INC11 citations92
US9238655B2Jan 19, 2016
Heteroaryl pyridone and aza-pyridone compounds
GENENTECH INC12 citations92
US8921353B2Dec 30, 2014
Heteroaryl pyridone and aza-pyridone compounds
GENENTECH INC16 citations92
US9782405B2Oct 10, 2017
Heteroaryl pyridone and aza-pyrodine compounds
GENENTECH INC9 citations84
US9260415B2Feb 16, 2016
Heteroaryl pyridone and aza-pyridone compounds with electrophilic functionality
GENENTECH INC16 citations84
US8669251B2Mar 11, 2014
8-fluorophthalazin-1(2H)-one compounds
GENENTECH INC10 citations84
USRE48239EOct 6, 2020
Heteroaryl pyridone and aza-pyridone compounds
GENENTECH INC3 citations73
US11566003B2Jan 31, 2023
Isoquinolines as inhibitors of HPK1
GENENTECH INC4 citations72
US10639373B2May 5, 2020
Pyrrolobenzodiazepine antibody drug conjugates and methods of use
GENENTECH INC2 citations72
US10533058B2Jan 14, 2020
Peptidomimetic compounds and antibody-drug conjugates thereof
GENENTECH INC2 citations72
US10058613B2Aug 28, 2018
Pyrrolobenzodiazepine antibody drug conjugates and methods of use
GENENTECH INC2 citations72
US11242344B2Feb 8, 2022
(4-hydroxypyrrolidin-2-yl)-heterocyclic compounds and methods of use thereof
GENENTECH INC5 citations71
US10407424B2Sep 10, 2019
Naphthyridines as inhibitors of HPK1
GENENTECH INC5 citations71
US10124069B2Nov 13, 2018
Peptidomimetic compounds and antibody-drug conjugates thereof
GENENTECH INC3 citations71
US11666581B2Jun 6, 2023
PROTAC antibody conjugates and methods of use
GENENTECH INC2 citations70
US8952043B2Feb 10, 2015
Benzoxepin PI3K inhibitor compounds and methods of use
GENENTECH INC3 citations62
US8754077B2Jun 17, 2014
8-fluorophthalazin-1(2H)-one compounds
GENENTECH INC2 citations62
US11944606B2Apr 2, 2024
Azaindoles as inhibitors of HPK1
GENENTECH INC0 citations61
US11692043B2Jul 4, 2023
Peptidomimetic compounds and antibody-drug conjugates thereof
GENENTECH INC0 citations61
US10952995B2Mar 23, 2021
Azaindoles as inhibitors of HPK1
GENENTECH INC0 citations61
US11612606B2Mar 28, 2023
8-aminoisoquinoline compounds and uses thereof
GENENTECH INC2 citations60
US11034692B1Jun 15, 2021
Naphthyridines as inhibitors of HPK1
GENENTECH INC1 citations60
US9175009B2Nov 3, 2015
Benzoxepin PI3K inhibitor compounds and methods of use
GENENTECH INC0 citations52
US10632196B2Apr 28, 2020
Pyrrolobenzodiazepine antibody drug conjugates and methods of use
GENENTECH INC0 citations51
US10632210B2Apr 28, 2020
Peptidomimetic compounds and antibody-drug conjugates thereof
GENENTECH INC0 citations51
US9999681B2Jun 19, 2018
Peptidomimetic compounds and antibody-drug conjugates thereof
GENENTECH INC1 citations51
US12297210B2May 13, 2025
Naphthyridine compounds and uses thereof
GENENTECH INC0 citations50
US12208088B2Jan 28, 2025
Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof
GENENTECH INC0 citations50
US12473301B2Nov 18, 2025
Isoquinoline compounds for the treatment of cancer
GENENTECH INC0 citations49
US12378249B2Aug 5, 2025
Isoquinoline compounds and uses thereof
GENENTECH INC0 citations49
US12152040B2Nov 26, 2024
Tert-butyl (s)-2-(4-(phenyl)-6H-thieno[3, 2-f][1, 2, 4]triazolo[4, 3-a] [1,4]diazepin-6-yl) acetate derivatives and related compounds as bromodomain BRD4 inhibitors for treating cancer
GENENTECH INC0 citations46
US12338256B2Jun 24, 2025
Aza-tetracyclic oxazepine compounds and uses thereof
GENENTECH INC0 citations44
US10544215B2Jan 28, 2020
1-(Chloromethyl)-2,3-dihydro-1H-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
GENENTECH INC0 citations37
US10442836B2Oct 15, 2019
1-(chloromethyl)-2,3-dihydro-1H-benzo[E]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
GENENTECH INC0 citations37